A blocking peptide containing 15 amino acids near the amino terminus of human TNFRSF14.
Points forts
Source
Synthetic
(Accession #: Q92956) The HVEM/TNFRSF14 Blocking Peptide has been validated for the following applications: Antibody Competition.
Caractéristiques techniques
| Marque | Novus Biologicals |
|---|
| Réf. B-LABO | BL-RE-104361 |
|---|
| Réf. fabricant | 18074405 |
|---|
| Gene ID (Entrez) | 8764 |
|---|
| Espèces | Human |
|---|
| Contenu et stockage | Store at -20 C. Avoid freeze-thaw cycles. |
|---|
| Formule | PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin. |
|---|
| À utiliser avec (application) | This Peptide is Useful as a Blocking Peptide for NBP1-76690. For Further Blocking Peptide Related Protocol, Click Here . |
|---|
| Alias de gène | CD270 antigen, CD40-like protein, Herpes virus entry mediator A, Herpesvirus entry mediator A, HveA, HVEMTR2HVEAATAR, LIGHTR, tumor necrosis factor receptor superfamily member 14, tumor necrosis factor receptor superfamily, member 14 (herpesvirus entrymediator), Tumor necrosis factor receptor-like 2, tumor necrosis factor receptor-like gene2 |
|---|
| Symbole de gène(s) | TNFRSF14 |
|---|
| Type de produit | HVEM/TNFRSF14 |
|---|
| Quantité | 0.05 mg |
|---|
| État réglementaire | RUO - research use only |
|---|
| Source | Synthetic |
|---|
| Consigne | 15 amino acids near the amino terminus of human TNFRSF14 |
|---|
Une question, une configuration particulière ?
Contactez-nous pour un devis.
